Yao‐Chang Xu
Io Therapeutics (United States)(US)
Publications by Year
Research Areas
Asymmetric Synthesis and Catalysis, Migraine and Headache Studies, Oxidative Organic Chemistry Reactions, Synthetic Organic Chemistry Methods, Nicotinic Acetylcholine Receptors Study
Most-Cited Works
- → Preclinical pharmacological profile of the selective 5-HT1Freceptor agonist lasmiditan(2010)208 cited
- → Conformational Preferences of π–π Stacking Between Ligand and Protein, Analysis Derived from Crystal Structure Data Geometric Preference of π–π Interaction(2015)124 cited
- → Oxidative C−C Bond-Forming Reaction of Electron-Rich Alkylbenzyl Ether with Trimethylvinyloxysilane(2004)81 cited
- → Stereoselective, Oxidative C−C Bond Coupling of Naphthopyran Induced by DDQ: Stereocontrolled Total Synthesis of Deoxyfrenolicin(1999)65 cited
- → Room Temperature Asymmetric Allylic Trifluoromethylation of Morita–Baylis–Hillman Carbonates(2011)58 cited
- → The Novel 5-Hydroxytryptamine1A Antagonist LY426965: Effects on Nicotine Withdrawal and Interactions with Fluoxetine(2000)58 cited
- → Stereoselective aldol addition reactions of Fischer carbene complexes via electronic tuning of the metal center for enolate reactivity(1994)33 cited
- → Preparation of 8-Amido-2-dimethylamino-1,2,3,4-tetrahydro-2-dibenzofurans and Several Fluorinated Derivatives via [3,3]-Sigmatropic Rearrangement of O-Aryloximes(2003)31 cited
- → N-Methyl-5-tert-butyltryptamine: A Novel, Highly Potent 5-HT1D Receptor Agonist(1999)27 cited
- → N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: A Potent, Selective, and Orally Active 5-HT1F Receptor Agonist Potentially Useful for Migraine Therapy(2001)26 cited